Literature DB >> 28269768

Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.

Shea J Andrews1, Debjani Das1, Kaarin J Anstey2, Simon Easteal1.   

Abstract

Recent genome wide association studies have identified a number of single nucleotide polymorphisms associated with late onset Alzheimer's disease (LOAD). We examined the associations of 24 LOAD risk loci, individually and collectively as a genetic risk score, with cognitive function. We used data from 1,626 non-demented older Australians of European ancestry who were examined up to four times over 12 years on tests assessing episodic memory, working memory, vocabulary, and information processing speed. Linear mixed models were generated to examine associations between genetic factors and cognitive performance. Twelve SNPs were significantly associated with baseline cognitive performance (ABCA7, MS4A4E, SORL1), linear rate of change (APOE, ABCA7, INPP5D, ZCWPW1, CELF1), or quadratic rate of change (APOE, CLU, EPHA1, HLA-DRB5, INPP5D, FERMT2). In addition, a weighted genetic risk score was associated with linear rate of change in episodic memory and information processing speed. Our results suggest that a minority of AD related SNPs may be associated with non-clinical cognitive decline. Further research is required to verify these results and to examine the effect of preclinical AD in genetic association studies of cognitive decline. The identification of LOAD risk loci associated with non-clinical cognitive performance may help in screening for individuals at greater risk of cognitive decline.

Entities:  

Keywords:  Alzheimer’s disease; cognitive aging; genetic epidemiology; genetic risk scores; longitudinal studies; single nucleotide polymorphisms

Mesh:

Year:  2017        PMID: 28269768     DOI: 10.3233/JAD-160774

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

Review 1.  Personality and Incident Alzheimer's Disease: Theory, Evidence, and Future Directions.

Authors:  Suzanne C Segerstrom
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-02-14       Impact factor: 4.077

2.  ABCA7 risk variant in healthy older African Americans is associated with a functionally isolated entorhinal cortex mediating deficient generalization of prior discrimination training.

Authors:  Neha Sinha; Zachariah M Reagh; Nicholas J Tustison; Chelsie N Berg; Ashlee Shaw; Catherine E Myers; Diane Hill; Michael A Yassa; Mark A Gluck
Journal:  Hippocampus       Date:  2018-12-10       Impact factor: 3.899

Review 3.  Genetic Insights into Alzheimer's Disease.

Authors:  Caitlin S Latimer; Katherine L Lucot; C Dirk Keene; Brenna Cholerton; Thomas J Montine
Journal:  Annu Rev Pathol       Date:  2021-01-24       Impact factor: 23.472

Review 4.  Role of ABCA7 in Human Health and in Alzheimer's Disease.

Authors:  Shiraz Dib; Jens Pahnke; Fabien Gosselet
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

5.  Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.

Authors:  Richard Sherva; Alden Gross; Shubhabrata Mukherjee; Ryan Koesterer; Philippe Amouyel; Celine Bellenguez; Carole Dufouil; David A Bennett; Lori Chibnik; Carlos Cruchaga; Jorge Del-Aguila; Lindsay A Farrer; Richard Mayeux; Leanne Munsie; Ashley Winslow; Stephen Newhouse; Andrew J Saykin; John S K Kauwe; Paul K Crane; Robert C Green
Journal:  Alzheimers Dement       Date:  2020-06-23       Impact factor: 16.655

6.  Meta-analysis of epigenome-wide association studies of cognitive abilities.

Authors:  Riccardo E Marioni; Allan F McRae; Jan Bressler; Elena Colicino; Eilis Hannon; Shuo Li; Diddier Prada; Jennifer A Smith; Letizia Trevisi; Pei-Chien Tsai; Dina Vojinovic; Jeannette Simino; Daniel Levy; Chunyu Liu; Michael Mendelson; Claudia L Satizabal; Qiong Yang; Min A Jhun; Sharon L R Kardia; Wei Zhao; Stefania Bandinelli; Luigi Ferrucci; Dena G Hernandez; Andrew B Singleton; Sarah E Harris; John M Starr; Douglas P Kiel; Robert R McLean; Allan C Just; Joel Schwartz; Avron Spiro; Pantel Vokonas; Najaf Amin; M Arfan Ikram; Andre G Uitterlinden; Joyce B J van Meurs; Tim D Spector; Claire Steves; Andrea A Baccarelli; Jordana T Bell; Cornelia M van Duijn; Myriam Fornage; Yi-Hsiang Hsu; Jonathan Mill; Thomas H Mosley; Sudha Seshadri; Ian J Deary
Journal:  Mol Psychiatry       Date:  2018-01-08       Impact factor: 15.992

7.  From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.

Authors:  Judith R Harrison; Sumit Mistry; Natalie Muskett; Valentina Escott-Price
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 8.  The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics.

Authors:  Arne De Roeck; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Acta Neuropathol       Date:  2019-03-22       Impact factor: 17.088

9.  Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes.

Authors:  Sigalit B Manzali; Eric Yu; Ramit Ravona-Springer; Abigail Livny; Sapir Golan; Yuxia Ouyang; Orit Lesman-Segev; Lang Liu; Ithamar Ganmore; Anna Alkelai; Ziv Gan-Or; Hung-Mo Lin; Anthony Heymann; Michal Schnaider Beeri; Lior Greenbaum
Journal:  Front Aging Neurosci       Date:  2022-08-30       Impact factor: 5.702

10.  The Effects of APOE and ABCA7 on Cognitive Function and Alzheimer's Disease Risk in African Americans: A Focused Mini Review.

Authors:  Chelsie N Berg; Neha Sinha; Mark A Gluck
Journal:  Front Hum Neurosci       Date:  2019-11-05       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.